# HemeOncBuddy — Heme/Onc boards & study hub

> Hematology and Oncology clinical trial summaries for medical professionals. (iPhone/iPad app by Veli Bakalov.)

- Source: https://appshunter.io/ios/app/hemeoncbuddy/id1579207336 (this page in markdown: same URL + `.md`)
- Developer: [Veli Bakalov](https://appshunter.io/developer/1579207338)
- Category: Medical, Education
- Price: Free
- Rating: 5.00/5 from 17 App Store ratings · 2 written reviews indexed
- Age rating: 17+
- Requires: iOS 15.0 · 16 MB
- Languages: American English
- Released: 2021-09-02
- Data updated: 2026-08-05
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/hemeoncbuddy/id1579207336/reviews.md

## What is HemeOncBuddy?

HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app.

WHAT'S INSIDE
- 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly.
- A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking.
- ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks.
- 120+ concise disease-site board-prep notes.
- A conference & abstract-deadline tracker so you never miss a submission window.

MADE FOR STUDYING
- Full dark mode and adjustable text size.
- Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac.
- No ads. No paywall. No login required to browse.

HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.

## Key features

- Practice-changing clinical trial summaries
- Hematology and Oncology focus
- Simplified trial information
- Inclusion and exclusion criteria
- Primary endpoints and outcomes
- Quick reference tool

## Recent user reviews (2 of 2)

All indexed reviews: https://appshunter.io/ios/app/hemeoncbuddy/id1579207336/reviews.md

### 5/5 — Excellent

*2022-02-02*

Excellent app !!! Way to go my friend Dr. Bakalov.

### 5/5 — Great app

*2021-09-03*

This is a super app. I want direct cerebral download for version 2 please.

## Frequently asked questions about HemeOncBuddy

### What is HemeOncBuddy?

HemeOncBuddy is a free medical app designed to provide quick access to important and practice-changing clinical trials in Hematology and Oncology. It organizes trial summaries in a simplified format for easy reference.

### Who is HemeOncBuddy for?

This app is intended for medical professionals, researchers, and students who need to stay updated on the latest advancements in Hematology and Oncology research.

### What kind of information does HemeOncBuddy provide on clinical trials?

Each trial summary includes background information, inclusion and exclusion criteria, primary endpoints, median follow-up, and outcomes on primary endpoints.

### Is HemeOncBuddy available on multiple devices?

Yes, HemeOncBuddy is available for iPhone, iPad, and iPod devices, catering to a wide range of iOS users.

### How often is HemeOncBuddy updated?

The app was last updated on October 10, 2023, indicating ongoing maintenance and potential content refreshes.

### What is the age rating for HemeOncBuddy?

HemeOncBuddy has an age rating of 17+, suggesting it contains content suitable for mature audiences.

### Does HemeOncBuddy have ads?

No, HemeOncBuddy does not contain advertisements, providing an uninterrupted user experience.

### What is the user feedback on HemeOncBuddy?

HemeOncBuddy has received excellent user feedback, holding a perfect 5.0-star rating from 17 ratings.

## Version history (last 4 releases)

### 4.0 — 2026-07-31

A major update:
- Full dark mode across the entire app
- New Question Bank - board-style questions with tutor/timed modes, explanations, and progress tracking
- ~2,000 board-prep flashcards, including visual staging decks
- Conference & abstract-deadline tracker
- Optional account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across devices
- Redesigned navigation, reading view, and menus
- Many readability and accessibility improvements

### 3.0 — 2023-10-10

- Exciting App Update!
- Enhanced organisation with categorised menu of all trials 
- Improved iPad view (compatible with MacOS with M1 and above) 
- Customisable text size 
- Lecture notes for HemeOnc Boards. 
- Explore now!

### 2.0 — 2021-10-22

interface optimization, performance improvements. 
~170 trials now

### 1.0 — 2021-09-02

No release notes.

## Apps similar to HemeOncBuddy

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [Hem/Onc @Point of Care](https://appshunter.io/ios/app/hemonc-point-of-care/id1232656473) | 5.0 (2) | Free | Medical |
| [Immuno-Oncology](https://appshunter.io/ios/app/immuno-oncology/id929744778) | 3.5 (2) | Free | Medical |
| [Physicians Cancer Chemotherapy](https://appshunter.io/ios/app/physicians-cancer-chemotherapy/id1361675468) | 4.8 (240) | Free | Medical |
| [Primum](https://appshunter.io/ios/app/primum/id6651755259) | 4.2 (5) | Free | Medical |
| [Cancer Pharmacology Manual](https://appshunter.io/ios/app/cancer-pharmacology-manual/id1572225415) | 5.0 (2) | Free | Medical |
| [Manual of Clinical Oncology](https://appshunter.io/ios/app/manual-of-clinical-oncology/id883379133) | 4.5 (18) | Free | Medical |

## Related topics

[asco sep](https://appshunter.io/ios/topics/asco-sep) · [ebmt educational tools](https://appshunter.io/ios/topics/ebmt-educational-tools)

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-08-05.*